ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*J0009290-CORR013701028CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120241023W173deBibliographieenBibliographyfrBibliographieEP18815370.4201810242020052220210526enenen201762576277 P20171024US201862664800 P20180430US201862673039 P20180517US201862690284 P20180626US201862746900 P20181017US2024102320244320200902202036202409112024372024040420241023202443C12N 15/113 20100101AFI20190503BHEP C12N 15/90 20060101ALI20190503BHEP C12N 9/22 20060101ALI20190503BHEP A61P 37/02 20060101ALI20190503BHEP A61K 48/005 20130101 LI20190411BHEP C12N 9/22 20130101 LI20190211BHEP C12N 15/113 20130101 FI20190211BHEP C12N 15/907 20130101 LI20190211BHEP C12N2750/14143 20130101 LA20190411BHEP C12N2310/20 20170501 LA20190211BHEP A61P 37/02 20180101 LI20190527BHEP A61K 39/461 20230501 LI20240322RHEP A61K 39/4611 20230501 LI20240322RHEP A61K 39/464411 20230501 LI20240322RHEP deSYSTEME UND VERFAHREN ZUR BEHANDLUNG VON HYPER-IGM-SYNDROMenSYSTEMS AND METHODS FOR TREATING HYPER-IGM SYNDROMEfrSYSTÈMES ET MÉTHODES DE TRAITEMENT DU SYNDROME D'HYPER-IGMWO-A1-2016/183345TAHARA MINORU ET AL: "Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency", NATURE MEDICINE, vol. 10, no. 8, 25 July 2004 (2004-07-25), New York, pages 835 - 841, XP055805708, ISSN: 1078-8956, Retrieved from the Internet <URL:https://www.nature.com/articles/nm1086.pdf> DOI: 10.1038/nm1086TAHARA MINORU ET AL: "Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency - Supplementary Methods", NATURE MEDICINE, 25 July 2004 (2004-07-25), XP055805730, Retrieved from the Internet <URL:https://static-content.springer.com/esm/art:10.1038/nm1086/MediaObjects/41591_2004_BFnm1086_MOESM4_ESM.pdf> [retrieved on 20210519]CAROLINE KUO: "Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome", CDI SYMPOSIUM 2016, May 2016 (2016-05-01), XP055554527, Retrieved from the Internet <URL:https://www.uclahealth.org/mattel/cdi/workfiles/Symposium/2016/CKuo-CDI-Symposium-2016.pdf> [retrieved on 20190211]HUBBARD NICHOLAS ET AL: "Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome", BLOOD, vol. 127, no. 21, 22 February 2016 (2016-02-22), US, pages 2513 - 2522, XP055397792, ISSN: 0006-4971, DOI: 10.1182/blood-2015-11-683235NICHOLAS HUBBARD ET AL: "Supplemental Methods", BLOOD, 22 February 2016 (2016-02-22), XP055554515, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/bloodjournal/suppl/2016/02/22/blood-2015-11-683235.DC1/blood-2015-11-683235-1.pdf> [retrieved on 20190211]DAISUKE TOMIZAWA ET AL: "Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: A single center experience", AMERICAN JOURNAL OF HEMATOLOGY, vol. 76, no. 1, 20 May 2004 (2004-05-20), US, pages 33 - 39, XP055554737, ISSN: 0361-8609, DOI: 10.1002/ajh.20044CAROLINE Y. KUO ET AL: "121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome", MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY, vol. 23, May 2015 (2015-05-01), US, pages S50, XP055554579, ISSN: 1525-0016, DOI: 10.1016/S1525-0016(16)33726-1CAROLINE Y. KUO ET AL: "Site Specific Gene Correction of Defects in CD40 Ligand Using the Crispr/Cas9 Genome Editing Platform", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 135, no. 2, 2 February 2015 (2015-02-02), AMSTERDAM, NL, pages AB17, XP055554584, ISSN: 0091-6749, DOI: 10.1016/j.jaci.2014.12.987CAROLINE Y. KUO ET AL: "Patient Specific Targeted Gene Therapy In The Treatment Of X-Linked Hyper-IgM Syndrome", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 133, no. 2, 23 January 2014 (2014-01-23), AMSTERDAM, NL, pages AB162, XP055554585, ISSN: 0091-6749, DOI: 10.1016/j.jaci.2013.12.588MATTHEW H. PORTEUS: "Knock-in editing: it functionally corrects!", BLOOD, vol. 127, no. 21, 26 May 2016 (2016-05-26), US, pages 2507 - 2509, XP055554520, ISSN: 0006-4971, DOI: 10.1182/blood-2016-03-703181A. JAIN ET AL: "Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand", BLOOD, vol. 118, no. 14, 12 August 2011 (2011-08-12), US, pages 3811 - 3817, XP055554490, ISSN: 0006-4971, DOI: 10.1182/blood-2011-04-351254JULIETTE M. K. M. DELHOVE ET AL: "Genome-Edited T Cell Therapies", CURRENT STEM CELL REPORTS, vol. 3, no. 2, 18 April 2017 (2017-04-18), pages 124 - 136, XP055554337, DOI: 10.1007/s40778-017-0077-5CAROLINE Y. KUO ET AL: "Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome", CELL REPORTS, vol. 23, no. 9, 29 May 2018 (2018-05-29), US, pages 2606 - 2616, XP055554129, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2018.04.103COTTA-RAMUSINO, Cecillia36 Prince Street Unit ACambridge,MA 02139USMARGULIES, Carrie, M.14 Samoset RoadWaban,MA 02468USNALDINI, LuigiVia Olegettina 6020132 MilanITGENOVESE, PietroVia Olgettina 6020132 MilanITEditas Medicine, Inc.101654496P116439EP11 Hurley StreetCambridge, MA 02141USFondazione Telethon ETS101960810P116439EPVia Varese 16B00185 RomaITOspedale San Raffaele S.r.l.102061887P116439EPVia Olgettina, 6020132 MilanoITD Young & Co LLP1015335513 Noble StreetLondon EC2V 7BQGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201805735420181024enWO201908416820190502201918